mhurhangee/ep-ind-claims huggingface dataset:
Method for the management of a file system for accessing data in a storage system in which the data is stored physically in a unique manner, with the method comprising: - the mounting (100, with i=1), from a first mount point, of a first storage environment associated with a first set of access parameters, to access all or a portion of the data physically stored in a unique manner in the storage system, with an access performance level (QoS_1) determined by said first set of parameters; - the mounting (100, with i=2), from a second mount point and with total or partial overlay of data with respect to the first storage environment, of at least one second storage environment, different from the first storage environment, and associated with a second set of access parameters, different from the first set of access parameters, to access all or a portion of the data physically stored in a unique manner in the storage system, with an access performance level (QoS_2) determined by said second set of access parameters; and, - access by the user to the data physically stored in a unique manner in the storage system, either via the first mount point or via the second mount point, as a function of a data use case. - the mounting (100, with i=1), from a first mount point, of a first storage environment associated with a first set of access parameters, to access all or a portion of the data physically stored in a unique manner in the storage system, with an access performance level (QoS_1) determined by said first set of parameters; - the mounting (100, with i=2), from a second mount point and with total or partial overlay of data with respect to the first storage environment, of at least one second storage environment, different from the first storage environment, and associated with a second set of access parameters, different from the first set of access parameters, to access all or a portion of the data physically stored in a unique manner in the storage system, with an access performance level (QoS_2) determined by said second set of access parameters; and, - access by the user to the data physically stored in a unique manner in the storage system, either via the first mount point or via the second mount point, as a function of a data use case.
A turbine arrangement with a radial inlet and radial outlet flow rotor for bi-directional reversing flow comprising a rotor with blades and a stator with two sets of guide vanes (7,8), the turbine arrangement having an axis, said rotor rotably mounted to rotate about the axis and having a plurality of rotor blades disposed circumferentially around the rotor; • said blades forming flow channels from rotor entry to rotor exit, said rotor having on its outer radial periphery two apertures (5, 6) in a radial direction axially offset from each other, the entrance of fluid into the rotor through any of the two apertures being centripetal and the exit of fluid from the rotor through any of the two apertures being centrifugal; • the first set of guide vanes being circumferentially disposed about the axis and located at a greater radius with respect to the corresponding rotor aperture in the path of the flow incoming to it or coming out of it and located in radial alignment of the respective rotor aperture; • a duct connecting the first set of guide vanes with the corresponding rotor aperture, preferably formed by walls of revolution (10, 11); • the second set of guide vanes being circumferentially disposed about the axis and located at a greater radius with respect to the corresponding rotor aperture in the path of the flow incoming to it or coming out of it and located in radial alignment of the respective rotor aperture; • a duct connecting the second set of guide vanes with the corresponding rotor aperture, preferably formed by walls of revolution (13, 14). • said blades forming flow channels from rotor entry to rotor exit, said rotor having on its outer radial periphery two apertures (5, 6) in a radial direction axially offset from each other, the entrance of fluid into the rotor through any of the two apertures being centripetal and the exit of fluid from the rotor through any of the two apertures being centrifugal; • the first set of guide vanes being circumferentially disposed about the axis and located at a greater radius with respect to the corresponding rotor aperture in the path of the flow incoming to it or coming out of it and located in radial alignment of the respective rotor aperture; • a duct connecting the first set of guide vanes with the corresponding rotor aperture, preferably formed by walls of revolution (10, 11); • the second set of guide vanes being circumferentially disposed about the axis and located at a greater radius with respect to the corresponding rotor aperture in the path of the flow incoming to it or coming out of it and located in radial alignment of the respective rotor aperture; • a duct connecting the second set of guide vanes with the corresponding rotor aperture, preferably formed by walls of revolution (13, 14).
A controlled release oral pharmaceutical composition comprising a population of isosorbide dinitrate and hydralazine, or a salt thereof,-containing particles, wherein at least a portion of the particles incorporates: a modified-release coating comprising a material selected from copolymers of methacrylic acid, such that the composition following oral delivery to a subject delivers the isosorbide dinitrate and hydralazine, or salt thereof, in a pulsatile or zero order manner.
An electroacoustic transducer (1; 200; 300; 400; 500) comprising: - a ring-shaped magnetic assembly that generates a magnetic field, - a coil disposed in the magnetic field generated by the magnetic assembly such that the coil can move with respect to the magnetic assembly and vice versa, - an acoustic membrane connected to the coil or to the magnetic assembly in order to vibrate and emit a sound, and - at least one elastic suspension (4; 204; 304) connecting the acoustic membrane to the magnetic assembly or to the coil to permit the vibration of the acoustic membrane, characterized in that said magnetic assembly comprises: - a housing structure with annular shape, made of non-ferromagnetic material, and - a plurality of magnets having a magnetic axis and axial anisotropy; said magnets being disposed side by side, inside said support structure and each magnet having magnetic flux lines that are mutually parallel and parallel to the magnetic axis of the magnet, wherein the magnetic axis of the magnets is directed towards the center of the ring-shaped magnetic assembly, wherein said housing structure of the magnetic assembly acts as containment structure for the magnets. - a ring-shaped magnetic assembly that generates a magnetic field, - a coil disposed in the magnetic field generated by the magnetic assembly such that the coil can move with respect to the magnetic assembly and vice versa, - an acoustic membrane connected to the coil or to the magnetic assembly in order to vibrate and emit a sound, and - at least one elastic suspension (4; 204; 304) connecting the acoustic membrane to the magnetic assembly or to the coil to permit the vibration of the acoustic membrane, - a housing structure with annular shape, made of non-ferromagnetic material, and - a plurality of magnets having a magnetic axis and axial anisotropy; said magnets being disposed side by side, inside said support structure and each magnet having magnetic flux lines that are mutually parallel and parallel to the magnetic axis of the magnet, wherein the magnetic axis of the magnets is directed towards the center of the ring-shaped magnetic assembly, wherein said housing structure of the magnetic assembly acts as containment structure for the magnets.
A mouse comprising a genetic modification, wherein the genetic modification comprises a replacement of a genomic fragment of the endogenous mouse low affinity FcγR gene locus, wherein said genomic fragment comprises the mouse genes encoding FcγRIIB, FcγRIV and FcγRIII α-subunits, with a human genomic fragment that encodes at least two low affinity human FcγR genes selected from human FcγRIIA, FcγRIIB, FcγRIIC, FcγRIIIA and FcγRIIIB, and wherein the mouse comprises a functional FcR γ-chain.
A lateral flow analyte test device, comprising: (a) a test strip comprising an uncompressible and nonabsorbent base layer, a first bibulous material disposed on the base layer at a proximal end thereof and forming a sample receiving region, a second bibulous material disposed on the base layer at a distal end thereof and forming an absorbent region, wherein the second bibulous material is compressible, and a porous membrane disposed on the base layer between the proximal and distal ends (201, 203) thereof and fluidly connected to the first bibulous material and the second bibulous material, the test strip defining a flow path wherein a sample applied to the sample receiving region flows through the porous membrane to the absorbent region, wherein the porous membrane comprises one or more test zones, each test zone comprising one or more reagents configured to bind for detection one or more analyte of interest; (b) a rigid base which supports the test strip, the base comprising a first vertical wall and a second vertical wall forming a recess which receives the base layer therewithin at the distal end of the base layer, the width of the recess being equal to the width dimension of the base layer, the first vertical wall comprising one or more first structures formed thereon above the level of the base layer, and the second vertical wall comprising one or more second structures formed thereon above the level of the base layer, wherein the first and second structures are configured to retain the test strip within the base. (a) a test strip comprising an uncompressible and nonabsorbent base layer, a first bibulous material disposed on the base layer at a proximal end thereof and forming a sample receiving region, a second bibulous material disposed on the base layer at a distal end thereof and forming an absorbent region, wherein the second bibulous material is compressible, and a porous membrane disposed on the base layer between the proximal and distal ends (201, 203) thereof and fluidly connected to the first bibulous material and the second bibulous material, the test strip defining a flow path wherein a sample applied to the sample receiving region flows through the porous membrane to the absorbent region, wherein the porous membrane comprises one or more test zones, each test zone comprising one or more reagents configured to bind for detection one or more analyte of interest; (b) a rigid base which supports the test strip, the base comprising a first vertical wall and a second vertical wall forming a recess which receives the base layer therewithin at the distal end of the base layer, the width of the recess being equal to the width dimension of the base layer, the first vertical wall comprising one or more first structures formed thereon above the level of the base layer, and the second vertical wall comprising one or more second structures formed thereon above the level of the base layer, wherein the first and second structures are configured to retain the test strip within the base.
A system configured to determine radiation beam characteristics in a radiation treatment device using an electronic portal imaging device, EPID,, the system being configured to perform the steps of: acquiring one or more images using the imaging device, the imaging device including a plurality of pixels; determining one or more parameters from the one or more images; and determining one or more characteristics of the radiation beam from the determined one or more parameters, wherein the one or more characteristics includes number of detected photons, radiation beam energy change, radiation beam tilt relative to a collimator axis of rotation, radiation beam symmetry, radiation beam flatness, and radiation beam center change; characterized in that the determination of the one or more characteristics is independent of pixel gain and/or pixel sensitivity, and wherein determining the number of detected photons comprises: generating a plurality of images; measuring pixel values and one or more noise values of a pixel across the plurality of images; calculating the mean pixel value of the pixel from the measured pixel values; and determining a value corresponding to detected photons per pixel based on the mean pixel value and the one or more noise values for the pixel. acquiring one or more images using the imaging device, the imaging device including a plurality of pixels; determining one or more parameters from the one or more images; and determining one or more characteristics of the radiation beam from the determined one or more parameters, wherein the one or more characteristics includes number of detected photons, radiation beam energy change, radiation beam tilt relative to a collimator axis of rotation, radiation beam symmetry, radiation beam flatness, and radiation beam center change; characterized in that the determination of the one or more characteristics is independent of pixel gain and/or pixel sensitivity, and wherein determining the number of detected photons comprises: generating a plurality of images; measuring pixel values and one or more noise values of a pixel across the plurality of images; calculating the mean pixel value of the pixel from the measured pixel values; and determining a value corresponding to detected photons per pixel based on the mean pixel value and the one or more noise values for the pixel. generating a plurality of images; measuring pixel values and one or more noise values of a pixel across the plurality of images; calculating the mean pixel value of the pixel from the measured pixel values; and determining a value corresponding to detected photons per pixel based on the mean pixel value and the one or more noise values for the pixel.
A method of configuring a frame structure in a radio access system supportive of full duplex radio, FDR, transmission, the method comprising: sending, to a user equipment, UE, a capability enquiry message; receiving, from the UE, a UE capability information message including a field indicating that FDR transmission is supported by the UE; assigning a downlink, DL, control channel and a DL data channel to a prescribed subframe of a serving cell; assigning an uplink, UL, data channel to the prescribed subframe for the FDR transmission of the serving cell; allocating an empty region by nulling a resource region in the UL data channel, wherein the resource region is a part of the UL data channel and corresponds to the DL control channel; and transmitting, to the UE, resource allocation information for the prescribed subframe, wherein the FDR transmission is performed in a manner that a UL transmission and a DL transmission are simultaneously performed in a same region of the prescribed subframe. sending, to a user equipment, UE, a capability enquiry message; receiving, from the UE, a UE capability information message including a field indicating that FDR transmission is supported by the UE; assigning a downlink, DL, control channel and a DL data channel to a prescribed subframe of a serving cell; assigning an uplink, UL, data channel to the prescribed subframe for the FDR transmission of the serving cell; allocating an empty region by nulling a resource region in the UL data channel, wherein the resource region is a part of the UL data channel and corresponds to the DL control channel; and transmitting, to the UE, resource allocation information for the prescribed subframe, wherein the FDR transmission is performed in a manner that a UL transmission and a DL transmission are simultaneously performed in a same region of the prescribed subframe.
Roll of a double-sided adhesive tape wound around a core, said tape comprising first and second major adhesive surfaces and at least one adhesive layer comprising a structural adhesive providing said second major adhesive surface, - the first major adhesive surface being protected by a first liner; - the second major adhesive surface being protected by a second liner, and - the second liner extending over the two edges (8, 9) of the second major surface to cover at least part of each first and second minor surfaces (6, 7) of the tape. - the first major adhesive surface being protected by a first liner; - the second major adhesive surface being protected by a second liner, and - the second liner extending over the two edges (8, 9) of the second major surface to cover at least part of each first and second minor surfaces (6, 7) of the tape.
A method comprising: performing, by a device in a network, anomaly detection functions using a machine learning-based anomaly detector to detect anomalous traffic in the network; identifying, by the device, an ability of one or more nodes in the network to perform at least one of the anomaly detection functions; selecting, by the device, a particular one of the anomaly detection functions to offload to a particular one of the nodes, based on the ability of the particular node to perform the particular anomaly detection function; and instructing, by the device, the particular node to perform the selected anomaly detection function. performing, by a device in a network, anomaly detection functions using a machine learning-based anomaly detector to detect anomalous traffic in the network; identifying, by the device, an ability of one or more nodes in the network to perform at least one of the anomaly detection functions; selecting, by the device, a particular one of the anomaly detection functions to offload to a particular one of the nodes, based on the ability of the particular node to perform the particular anomaly detection function; and instructing, by the device, the particular node to perform the selected anomaly detection function.
A method for detecting a first tag in an area monitored by one or more beacons, the first tag comprising a magnetic induction module and a transmitter, the method comprising the following steps at said tag: - receiving, by means of said magnetic induction module, a first beacon message as variations in a magnetic field, said first beacon message comprising beacon information; - extracting said beacon information from said first beacon message; - conditionally on said beacon information, transmitting or not transmitting a localisation message by means of said transmitter, wherein said beacon information comprises operating range information, said operating range information indicating a type of the beacon that emitted said first beacon message; the method further comprising: conditionally on said type, reducing a sensitivity of said magnetic induction module. - receiving, by means of said magnetic induction module, a first beacon message as variations in a magnetic field, said first beacon message comprising beacon information; - extracting said beacon information from said first beacon message; - conditionally on said beacon information, transmitting or not transmitting a localisation message by means of said transmitter,
A β forged titanium alloy material, wherein an area fraction of non-flattened grains, which are prior β grains having an aspect ratio of 3 or less, a forging-direction diameter of 20 μm or more, and a proportion of an α-phase in the crystal grain boundary of 80% or more, is less than 10%; an area fraction of flattened grains, which are prior β grains having an aspect ratio exceeding 3, a forging-direction diameter of 20 μm or more but not more than 700 μm, and a proportion of an α-phase in the crystal grain boundary of 80% or more, is 85% or more; and an average misorientation of crystal orientation of the α-phase precipitated along the grain boundary of the flattened grains is 6° or more, the β forged titanium alloy material comprising a titanium alloy having a Mo equivalent [Mo]eq, which is represented by the following formula, of more than 2.7 but less than 15: Mo eq = Mo + Ta / 5 + Nb / 3.6 + W / 2.5 + V / 1.5 + 1.25 Cr + 1.25 Ni + 1.7 Mn + 1.7 Co + 2.5 Fe (wherein, each element symbol in the parentheses on the right side of the formula represents a content [mass%] of each element in the titanium alloy).
Synthetic peptides of the general formula 1 [SEQ ID NO:1] H- XDL-XDL1- XDL2 - L- Lys - L-Leu - XDL3 - L-Thr -R2, where: H is hydrogen, XDL is absence of amino acid or L-Tyr, XDL1 is one of the following amino acids: L-Leu, L-Ala or D-Ala, XDL2 is one of the following amino acids: D-His, L-Ala or D-Ala, XDL3 is one of the following amino acids: L-Gln; R2 is OMe or NH 2, or peptides - retro-inversions of the formula which have reverse sequence of amino acids with replacement of L-form of amino acids with D-form and D-form of amino acids with L-form in the general formula 2 [SEQ ID NO:2] H- D-Thr -XDL4- D-Leu - D- Lys - XDL5- XDL6 - XDL7 -R2, where: H is hydrogen, XDL4 is one of the following amino acids: D-Gln; XDL5 is one of the following amino acids: L-His, D-Ala or L-Ala, XDL6 is one of the following amino acids: D-Leu, D-Ala or L-Ala, XDL7 is absence of amino acid or D-Tyr, R2 is OMe or NH 2, as anesthetic preparations with non-narcotic type of analgesic action. H is hydrogen, XDL is absence of amino acid or L-Tyr, XDL1 is one of the following amino acids: L-Leu, L-Ala or D-Ala, XDL2 is one of the following amino acids: D-His, L-Ala or D-Ala, XDL3 is one of the following amino acids: L-Gln; R2 is OMe or NH 2, or peptides - retro-inversions of the formula which have reverse sequence of amino acids with replacement of L-form of amino acids with D-form and D-form of amino acids with L-form in the general formula 2 [SEQ ID NO:2] H- D-Thr -XDL4- D-Leu - D- Lys - XDL5- XDL6 - XDL7 -R2, where: H is hydrogen, XDL4 is one of the following amino acids: D-Gln; XDL5 is one of the following amino acids: L-His, D-Ala or L-Ala, XDL6 is one of the following amino acids: D-Leu, D-Ala or L-Ala, XDL7 is absence of amino acid or D-Tyr, R2 is OMe or NH 2, as anesthetic preparations with non-narcotic type of analgesic action. H is hydrogen, XDL4 is one of the following amino acids: D-Gln; XDL5 is one of the following amino acids: L-His, D-Ala or L-Ala, XDL6 is one of the following amino acids: D-Leu, D-Ala or L-Ala, XDL7 is absence of amino acid or D-Tyr, R2 is OMe or NH 2, as anesthetic preparations with non-narcotic type of analgesic action.